Vikram Punia: "Our key goal is to reduce dependence of the country on drug imports"
The saturation of the Russian market with modern domestic products, not inferior to imported analogues, is becoming especially topical upon the complex international relationships throughout the world. This task is successfully solved in Pharmasyntez, which consistently develops new nosological directions, fixing the most "sensitive issues" of the Russian pharmaceutical industry. We asked Vikram PUNIA, President of Pharmasyntez JSC, to share his vision of the company's strategy and talk about the results achieved.